AI Agent Governance Checklist for Dental Service Organizations
A governance-ready DSO AI agent deployment requires four verifiable controls: a unique non-person identity for each agent, use-case-scoped least-privilege permissions, runtime policy enforcement at the point of tool-call execution, and audit logging that satisfies HIPAA technical safeguards across every practice location.
Four Governance Pillars for DSO AI Agents
Agent Identity
Unique, auditable non-person entity identity for each agent.
Least Privilege
Permissions scoped to a single use case, not the full EHR or PMS.
Runtime Enforcement
Policy applied at tool-call execution, not in the prompt.
Auditability
Agent actions logged as distinct, reviewable event types.
Why DSOs Need a Dedicated AI Agent Governance Framework
Dental Service Organizations are deploying AI agents for scheduling, patient intake, clinical documentation, billing, and patient communication across networks of practice locations. Each use case introduces a distinct access pattern to protected health information, and each typically runs on a different practice management or EHR variant depending on the location. HIPAA's Security Rule technical safeguards under 45 CFR 164.312 require access control, unique user identification, audit controls, and integrity controls for any system that creates, receives, maintains, or transmits ePHI. These obligations apply to AI agents in the same way they apply to any system component handling patient data, regardless of whether the agent is described as autonomous, assistive, or rules-based. A governance framework built for DSOs needs to translate these general requirements into controls that can be verified at the agent level and enforced consistently across every location, not just documented at the corporate level.
Agent Identity and Least Privilege as the Foundation
HIPAA's unique user identification requirement under 164.312(a)(2)(i) is most defensible when each AI agent is issued its own non-person entity identity, separate from the human administrator who configured it. This distinction matters for audit trails: if an agent inherits a staff member's credentials, activity logs cannot reliably distinguish agent-initiated actions from human actions, which undermines the audit control requirement in 164.312(b). NIST SP 800-53 Rev 5 defines least-privilege controls (AC-6) and audit and accountability controls (the AU family) as applicable to both human and non-person entity identities, giving DSOs an established reference point for scoping agent access. HIPAA's minimum necessary standard under 45 CFR 164.502(b) reinforces this further by requiring that use and disclosure of PHI be limited to what the intended purpose requires. For an AI agent, that means the scheduling agent should not carry the same data access as the billing agent, even if both operate within the same practice management system.
Runtime Enforcement vs. Prompt-Level Restrictions
A recurring gap in agent deployments is treating prompt-level instructions as a substitute for an enforceable technical safeguard. Telling an agent not to access certain records through its system prompt is a behavioral suggestion, not a control that HIPAA's technical safeguards contemplate. OWASP's work on agentic application security identifies excessive agency, meaning permissions, functionality, or autonomy broader than a task requires, as a top-tier risk category for these systems. Runtime policy enforcement addresses this by evaluating each tool call against a defined policy at the moment of execution, independent of what the model was instructed to do in its prompt. For a multi-location DSO, this is best implemented through a centralized policy enforcement point that spans the practice management and EHR/PMS systems in use across locations, so that least-privilege scoping remains consistent even where underlying system versions differ by practice.
Multi-Location Audit and Documentation Considerations
Because DSOs operate across many practice locations, audit log review needs to function at both the individual location level and the enterprise level. A location administrator may need visibility into agent activity specific to that practice, while compliance leadership needs an aggregated view to satisfy HIPAA's audit control requirement across the organization as a whole. Separately, DSOs should evaluate whether any deployed agent incorporates predictive decision support functionality. ONC's HTI-1 Final Rule requires certified health IT developers to provide transparency information on predictive decision support interventions used in clinical workflows, which may apply depending on how an agent's documentation or clinical support functionality is built and certified.
Evaluation Criteria for Governance and Runtime Security Tooling
Use the following checklist to assess any AI agent deployment, or the platform that governs it, before expanding to additional locations or use cases.
- Confirm the platform assigns unique, auditable identity to each agent, separate from the human credentials used to configure it.
- Verify permissions can be scoped per use case rather than granted as blanket EHR or PMS access.
- Confirm runtime policy is enforced at the point of tool-call execution, not solely through model-level prompt instructions.
- Review whether audit logs capture every agent tool call with enough detail to support a HIPAA audit review across all locations.
- Confirm the vendor will execute a Business Associate Agreement specifying how agent-related PHI processing is governed.
Frequently Asked Questions
Does HIPAA specifically regulate AI agents?
No HHS guidance specifically addresses autonomous AI agents as a distinct category. HIPAA's existing technical safeguards under 45 CFR 164.312 apply to any system component handling ePHI, which is a reasonable basis for applying them to AI agents, but this is an inference from existing regulatory text rather than an explicit agent-specific rule.
What is "excessive agency" in the context of AI agents?
Excessive agency is an OWASP-identified risk category describing AI agents granted permissions, functionality, or autonomy broader than their task requires. In a DSO context, this would include a scheduling agent with billing system write access, which increases both security exposure and the scope of a potential compliance incident.
Is a Business Associate Agreement required for AI agent vendors?
HIPAA Security Rule obligations extend to business associates, which includes any third-party vendor processing PHI on a covered entity's behalf. If an AI agent vendor's system accesses PHI, that vendor is subject to HIPAA requirements contractually and technically, not through policy assurances alone.